Ommer Chohan - Profile and Investment Details

Investor Profile

Ommer Chohan is a Venture Capital, Private Equity Firm based in Boston, Massachusetts, United States with a diverse investment portfolio that includes companies such as Magenta Therapeutics, Remix Therapeutics, Vigil NeuroscienceQuartet Medicine, Gemini Therapeutics, Bicycle Therapeutics, Harbour Biomed, Aerovate Therapeutics, Generation Bio, Padlock Therapeutics, Lysosomal Therapeutics, UNUM Therapeutics, Scorpion Therapeutics, Disarm Therapeutics, Kymera Therapeutics, Avrobio, Veracode, Bridj, Cogent Biosciences, Ikena Oncology, Wedding Spot, Surface Oncology, Delinia, Quench Bio, Plastiq, Translate Bio, Akero Therapeutics, Skillz, Vedere Bio, PillPack, Nimbus Therapeutics, Kinaset Therapeutics, HotSpot Therapeutics, ZappRx, Indalo Therapeutics, Appcues, Rodin Therapeutics, Intellia Therapeutics, Secret Escapes, Replimune Group, Synlogic, InsightSquared, Dyne Therapeutics, SimpleReach, Obsidian Therapeutics, Paracosm, Xilio Therapeutics, Accent Therapeutics, Disc Medicine, Navitor Pharmaceuticals, Raze Therapeutics, Be Biopharma, Spero Therapeutics, Korro Bio, Arkuda Therapeutics, Cadent Therapeutics, JenaValve Technology, Appcito, Viridian Therapeutics, Day One Biopharmaceuticals, Q32 Bio, Kinvey, Triplet Therapeutics, Affinia Therapeutics, IFM Therapeutics, CardFlight, . Over time, Ommer Chohan has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Ommer Chohan is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Drug Discovery, Wellness, Women Founded, Immunotherapy, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Startups, Finance, Bioinformatics, Biotechnology, Drug Development, Precision Medicine, Clinical Trials, Gene Therapy, Technology Transfer, Health Diagnostics, Medical, Information Technology, B2B, Therapeutics, Cellular Therapy, Pharmaceuticals, Oncology may find it worthwhile to explore potential connections with Ommer Chohan, as their portfolio suggests a familiarity and interest in this area.

Understanding Ommer Chohan’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.